Philipp Boehm-Sturm

Mangala Srinivas¹, 

Philipp Boehm-Sturm², 

Markus Aswendt², 

Eberhard D. Pracht^2,3, 

Carl G. Figdor¹, 

I. Jolanda de Vries¹, 

Mathias Hoehn² 

¹Department of Tumor Immunology, Nijmegen Center for Molecular Life Sciences, Radboud University Medical Center, 

²In-Vivo-NMR Laboratory, Max Planck Institute for Neurological Research, 

³, German Center for Neurodegenerative Diseases (DZNE) 

Shuheng Liu^*,1, 

Katharina Tielking^*,1, 

Dario von Wedel¹, 

Melina Nieminen-Kelhä¹, 

Susanne Mueller^2,3, 

Philipp Boehm-Sturm^2,3, 

Peter Vajkoczy¹, 

Ran Xu¹ 

¹Department of Neurosurgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, and Berlin Institute of Health, 

²Department of Experimental Neurology and Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 

³NeuroCure Cluster of Excellence and Charité Core Facility 7T Experimental MRIs, Charité - Universitätsmedizin Berlin